Item Details

Dietary Supplements Containing Ephedra [electronic resource]: Health Risks and FDA's Oversight : Statement of Marcia Crosse, Acting Director, Health Care--Public Health and Science Issues, Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

United States General Accounting Office
Format
EBook; Book; Government Document; Online
Published
Washington, D.C. : U.S. General Accounting Office, [2003]
Language
English
Series
Testimony
SuDoc Number
GA 1.5/2:GAO-03-1042 T
Description
System requirements: Adobe Acrobat Reader.
Mode of Access: Internet from the GAO web site. Address as of 10/31/03: http://www.gao.gov/new.items/d031042t.pdf; current access is available via PURL.
Notes
  • Title from title screen (viewed on Oct. 31, 2003).
  • "For release ... July 23, 2003."
  • Paper version available from: General Accounting Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
  • Includes bibliographical references.
Series Statement
Testimony ; GAO-03-1042 T
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Access in Virgo Classic

  • LEADER 02315nam a2200433Ia 4500
    001 u3996482
    003 SIRSI
    005 20031031140447.0
    006 m d f
    007 cr an-
    008 031031s2003 dcu sb f000 0 eng d
    035
      
      
    a| (Sirsi) ocm53325746
    035
      
      
    a| (OCoLC)53325746
    037
      
      
    b| GAO (202)512-6000 (voice); (202)512-6061 (Fax); (202)512-2537 (TDD) f| paper copy
    040
      
      
    a| GPO c| GPO d| MvI
    043
      
      
    a| n-us---
    074
      
      
    a| 0546-D-01 (online)
    086
    0
      
    a| GA 1.5/2:GAO-03-1042 T
    100
    1
      
    a| Crosse, Marcia.
    245
    1
    0
    a| Dietary supplements containing ephedra h| [electronic resource] : b| health risks and FDA's oversight : statement of Marcia Crosse, Acting Director, Health Care--Public Health and Science Issues, before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / c| United States General Accounting Office.
    260
      
      
    a| Washington, D.C. : b| U.S. General Accounting Office, c| [2003]
    440
      
    0
    a| Testimony ; v| GAO-03-1042 T
    538
      
      
    a| System requirements: Adobe Acrobat Reader.
    538
      
      
    a| Mode of Access: Internet from the GAO web site. Address as of 10/31/03: http://www.gao.gov/new.items/d031042t.pdf; current access is available via PURL.
    500
      
      
    a| Title from title screen (viewed on Oct. 31, 2003).
    500
      
      
    a| "For release ... July 23, 2003."
    500
      
      
    a| Paper version available from: General Accounting Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
    504
      
      
    a| Includes bibliographical references.
    596
      
      
    a| 1
    650
      
    0
    a| Ephedra z| United States.
    650
      
    0
    a| Dietary supplements x| Government policy z| United States.
    650
      
    0
    a| Consumer protection z| United States.
    610
    1
    0
    a| United States. b| Food and Drug Administration x| Evaluation.
    776
    0
      
    a| Crosse, Marcia. t| Dietary supplements containing ephedra : health risks and FDA's oversights : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives h| 17 p. w| (OCoLC)53101888
    710
    1
      
    a| United States. b| General Accounting Office.
    856
    4
    0
    u| http://purl.access.gpo.gov/GPO/LPS37718
    999
      
      
    a| GA 1.5/2:GAO-03-1042 T w| SUDOC i| 3996482-1001 l| INTERNET m| UVA-LIB t| INTERNET

Availability

Google Preview

Read Online